Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma

Table 4 Changes of lymphocytes before and after treatment

	CD3+	CD4+	CD8+	NK	B
Before treatment	54.7% ± 18.5%	32.3% ± 11.9%	15.4% ± 7.0%	16.0% ± 9.3%	8.5% ± 5.3%
After treatment	76.9% ± 16.1%a	37.9% ± 11.0%	32.0% ± 14.8%a	23.8% ± 14.8%a	2.8% ± 3.1%a

^aP < 0.05. NK: Natural killer